EUVIMEDEUVIMED entdecken
Crossref

Win-win integration: A mitochondria targeted AIE photosensitizer for hypochlorite detection and type I & type II photodynamic therapy

Jiahao Ni, Lichao Yu, Yixuan Wang, Tong Yang, Yueqi Bai, Bowen Zheng, Manshan Liang, Xiaoxia Ye, Yun-Yun Quan, Feifei Lin, Zu-Sheng Huang

Analytica Chimica Acta · 2024

DOI: 10.1016/j.aca.2024.343035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2024. Verfasst von Jiahao Ni und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Macromolecular Drugs and Large-scale Manufacturing, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 3…. Hauptthemen laut MEDLINE: Photosensitizing Agents, Photochemotherapy, Hypochlorous Acid, Mitochondria. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Zhejiang Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Photodynamic therapy (PDT) is a pioneering and effective anticancer modality with low adverse effects and high selectivity. Hypochlorous acid or hypochlorite (HClO/ClO-) is a type of inflammatory cytokine. The abnormal increase of ClO- in tumor cells is related to tumor pathogenesis and may be a "friend" for the design and synthesis of responsive phototherapy agents. However, preparing responsive phototherapy agents for all-in-one noninvasive diagnosis and simultaneous in situ therapy in a complex tumor environment is highly desirable but still remains an enormously demanding task. RESULTS: An acceptor-π bridge-donor-π bridge-acceptor (A-π-D-π-A) type photosensitizer TPTPy was designed and synthesized based on the phenothiazine structure which was used as the donor moiety as well as a ClO- responsive group. TPTPy was a multifunctional mitochondria targeted aggregation-induced emission (AIE) photosensitizer which could quickly and sensitively respond to ClO- with fluorescence "turn on" performance (19-fold fluorescence enhancement) and enhanced type I reactive oxygen species (ROS) generation to effectively ablate hypoxic tumor cells. The detection limit of TPTPy to ClO- was calculated to be 185.38 nM. The well-tailored TPTPy anchoring to mitochondria and producing ROS in situ could disrupt mitochondria and promote cell apoptosis. TPTPy was able to image inflammatory cells and tumor cells through ClO- response. In vivo results revealed that TPTPy was successfully utilized for PDT in tumor bearing nude mice and exhibited excellent biological safety for major organs. SIGNIFICANCE AND NOVELTY: A win-win integration strategy was proposed to design a tumor intracellular ClO- responsive photosensitizer TPTPy capable of both type I and type II ROS production to achieve photodynamic therapy of tumor. This work sheds light on the win-win integration design by taking full advantage of the characteristics of tumor microenvironment to build up responsive photosensitizer for in situ PDT of tumor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsPhotochemotherapyHypochlorous AcidMitochondriaAnimalsHumansMiceReactive Oxygen SpeciesMice, Inbred BALB CPhenothiazinesMice, NudeAntineoplastic AgentsOptical ImagingCell Survival

Stichwörter der Autor:innen

AIEHypochlorite detectionMitochondria targetingType I & type II PDTWin-win integration

Substanzen

Photosensitizing AgentsHypochlorous AcidReactive Oxygen SpeciesPhenothiazinesAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Macromolecular Drugs and Large-scale Manufacturing, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China.
  • Department of Anesthesiology, The Second Clinical College of Wenzhou Medical University, Wenzhou, 325035, China.
  • State Key Laboratory of Macromolecular Drugs and Large-scale Manufacturing, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China. Electronic address: yyquan@wmu.edu.cn.
  • Department of Blood Transfusion, The People's Hospital of Cangnan, Wenzhou, 325800, China. Electronic address: linfeifeiy@163.com.
  • State Key Laboratory of Macromolecular Drugs and Large-scale Manufacturing, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, China. Electronic address: huangzusheng@wmu.edu.cn.

Förderung

  • Zhejiang Province Natural Science Foundation

Zitieren

APA

Ni, J., Yu, L., Wang, Y., Yang, T., Bai, Y., Zheng, B., Liang, M., Ye, X., Quan, Y. Y., Lin, F., & Huang, Z. S. (2024). Win-win integration: A mitochondria targeted AIE photosensitizer for hypochlorite detection and type I & type II photodynamic therapy. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2024.343035

Vancouver

Ni J, Yu L, Wang Y, Yang T, Bai Y, Zheng B, et al. Win-win integration: A mitochondria targeted AIE photosensitizer for hypochlorite detection and type I & type II photodynamic therapy. Analytica Chimica Acta. 2024. doi:10.1016/j.aca.2024.343035

BibTeX
@article{Ni2024,
  author = {Ni, Jiahao and Yu, Lichao and Wang, Yixuan and Yang, Tong and Bai, Yueqi and Zheng, Bowen and Liang, Manshan and Ye, Xiaoxia and Quan, Yun-Yun and Lin, Feifei and Huang, Zu-Sheng},
  title = {Win-win integration: A mitochondria targeted AIE photosensitizer for hypochlorite detection and type I & type II photodynamic therapy},
  journal = {Analytica Chimica Acta},
  year = {2024},
  doi = {10.1016/j.aca.2024.343035}
}
Kostenlos starten →